Actos Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver
Conditions:   Diabetes Mellitus, Type 2;   NASH - Nonalcoholic Steatohepatitis;   NAFLD Interventions:   Drug: Pioglitazone;   Drug: Empagliflozin;   Drug: Pioglitazone + Empagliflozin Sponsor:   Getz Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2021 Category: Research Source Type: clinical trials